Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Saudi Med ; 31(4): 424-7, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21727748

RESUMO

Glycogenic hepatopathy (GH ) is a rare cause of serum transaminase elevations in type 1 diabetes mellitus. We describe a 13-year-old male with a history of poorly controlled type 1 diabetes mellitus who presented with hepatomegaly and severe transaminase flares. Liver histology confirmed GH. Treatment consists of improving glycemic control. Hepatomegaly due to excess glycogen storage in poorly controlled type 1 diabetics has been associated with younger patients with poor glycemic control, occurring about 2-4 weeks after starting insulin treatment, and resolving upon glucose stabilization. We conclude that glycogenic hepatopathy can cause hepatomegaly and significant transaminase elevations in individuals with type I diabetes mellitus, The recovery of severe transaminase elevations in this patient illustrates the more benign course of GH, which is a condition with a far better prognosis. Clinician awareness of GH should prevent diagnostic delay and will provide better insight into the prevalence of GH.


Assuntos
Diabetes Mellitus Tipo 1/complicações , Hepatomegalia/etiologia , Glicogênio Hepático/metabolismo , Adolescente , Diabetes Mellitus Tipo 1/fisiopatologia , Hepatomegalia/diagnóstico , Hepatomegalia/patologia , Humanos , Hepatopatias/diagnóstico , Hepatopatias/etiologia , Hepatopatias/patologia , Masculino , Transaminases/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...